About this trial
Patients undergoing hemodialysis (HD) frequently exhibit elevated serum uric acid (SUA) levels, which are associated with cardiovascular risks, joint issues, and diminished quality of life (QoL). Aerobic exercise has been shown to improve cardiovascular health and reduce SUA levels in various populations, suggesting potential benefits for HD patients.
Objective: This study aimed to investigate the impact of aerobic exercise on serum uric acid (SUA) levels, functional capacity, and quality of life (QoL) in patients undergoing hemodialysis (HD).
Methods: This randomized controlled trial will recruit 32 participants, aged 40-60, undergoing HD. The intervention group (Group A) will participate in a structured 6-week aerobic exercise program, while the control group (Group B) will receive only conventional physical therapy. Pre- and post-intervention assessments included SUA levels, the Six-Minute Walk Test (6MWT), and the Kidney Disease Quality of Life Short Form (KDQOL-SF™)
Eligibility criteria
Qualifiers
Hemodialysis patients aged 40-60years
Patients are medically stable and able to participate in physical activity.
Participants are able to understand the commands.
Participants must be stable on hemodialysis for at least 3 months.
Disqualifiers
Patients with significant cardiovascular or respiratory diseases, or other conditions that could impair their ability to exercise.
Severe cognitive impairment or psychiatric conditions that could interfere with study participation.
patients with acute medical conditions.
Trial design
Treatments tested in this trial
- Aerobic Exercises
- Conventional Program